Literature DB >> 26315728

Surgical and medical treatment in patients with acute severe ulcerative colitis.

Rosario Fornaro1, Michela Caratto1, Ginevra Barbruni1, Francesco Fornaro1, Alexander Salerno1, Davide Giovinazzo1, Camilla Sticchi2, Elisa Caratto1.   

Abstract

Ulcerative colitis (UC) is a chronic inflammatory disease of the mucosa of the colorectum. The treatment of UC depends on the severity of symptoms and the extent of the disease. Acute severe colitis (ASC) occurs in 12-25% of patients with UC. Patients with ASC must be managed by a multidisciplinary team. Medically or surgically aggressive treatment is carried out with the final aim of reducing mortality. Intravenous administration of corticosteroids is the mainstay of the therapy. Medical rescue therapy based on cyclosporine or infliximab should be considered if there is no response to corticosteroids for 3 days. If there has been no response to medical rescue therapy after 4-7 days, the patient must undergo colectomy in emergency surgery. Prolonged observation is counterproductive, as over time it increases the risk of toxic megacolon and perforation, with a very high mortality rate. The best potential treatment is subtotal colectomy with ileostomy and preservation of the rectum. Emergency surgery in UC should not be seen as a last chance, but can be considered as a life-saving procedure. Colectomies in emergency setting are characterized by high morbidity rates but the mortality is low.
© 2015 Chinese Medical Association Shanghai Branch, Chinese Society of Gastroenterology, Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine and Wiley Publishing Asia Pty Ltd.

Entities:  

Keywords:  acute severe ulcerative colitis; corticosteroid; cyclosporin; inflammatory bowel disease; infliximab; surgical treatment

Mesh:

Substances:

Year:  2015        PMID: 26315728     DOI: 10.1111/1751-2980.12278

Source DB:  PubMed          Journal:  J Dig Dis        ISSN: 1751-2972            Impact factor:   2.325


  6 in total

Review 1.  Contemporary Medical Management of Acute Severe Ulcerative Colitis.

Authors:  Kaitlin G Whaley; Michael J Rosen
Journal:  Inflamm Bowel Dis       Date:  2019-01-01       Impact factor: 5.325

Review 2.  British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults.

Authors:  Christopher Andrew Lamb; Nicholas A Kennedy; Tim Raine; Philip Anthony Hendy; Philip J Smith; Jimmy K Limdi; Bu'Hussain Hayee; Miranda C E Lomer; Gareth C Parkes; Christian Selinger; Kevin J Barrett; R Justin Davies; Cathy Bennett; Stuart Gittens; Malcolm G Dunlop; Omar Faiz; Aileen Fraser; Vikki Garrick; Paul D Johnston; Miles Parkes; Jeremy Sanderson; Helen Terry; Daniel R Gaya; Tariq H Iqbal; Stuart A Taylor; Melissa Smith; Matthew Brookes; Richard Hansen; A Barney Hawthorne
Journal:  Gut       Date:  2019-09-27       Impact factor: 23.059

3.  Interleukin-27 Is a Potential Rescue Therapy for Acute Severe Colitis Through Interleukin-10-Dependent, T-Cell-Independent Attenuation of Colonic Mucosal Innate Immune Responses.

Authors:  Mairi H McLean; Caroline Andrews; Miranda L Hanson; Walter A Baseler; Miriam R Anver; Emilee Senkevitch; Aleksandra K Staniszewska; Christopher Smith; Luke C Davies; Julie Hixon; Wenqeng Li; Wei Shen; Lothar Steidler; Scott K Durum
Journal:  Inflamm Bowel Dis       Date:  2017-11       Impact factor: 5.325

Review 4.  Update on medical and surgical options for patients with acute severe ulcerative colitis: What is new?

Authors:  Rachel E Andrew; Evangelos Messaris
Journal:  World J Gastrointest Surg       Date:  2016-09-27

5.  A Case of Severe Ulcerative Colitis with Colonic Dilatation caused by Renal Mucinous Tubular and Spindle Cell Carcinoma.

Authors:  Monika Kukulska; Izabela Smola; Agnieszka Halon; Leszek Paradowski; Elzbieta Poniewierka; Radoslaw Kempinski; Abdulhabib Annabhani
Journal:  Euroasian J Hepatogastroenterol       Date:  2016-12-01

6.  Assessing the efficacy of TNF-alpha inhibitors in preventing emergency and emergent colectomies.

Authors:  Ruben Rajan; Matthew W Trinder; Johnny Lo; Mary Theophilus
Journal:  JGH Open       Date:  2019-08-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.